findmyKOL
Clinical trialNCT03675412RecruitingInterventional

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

SponsorWills EyeEnrollment80Glaucoma, Primary Open Angle
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow due to vasoconstriction.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Wills Eye Glaucoma Service

    Philadelphia, Pennsylvania, United States

    Anand Montravadi, MDJay L Katz, MDJonathan S Myers, MDMarlene R Moster, MDMichael J Pro, MDScott Fudemberg, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Dec 2018
Primary completion
30 Apr 2027
Completion
30 Jun 2027
Last update posted
20 Aug 2026
Registered enrollment
80
Registry id
NCT03675412
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.